Image

A Study of Safety Tolerability and Clinical Activity of MEDI4736 and Tremelimumab Administered as Monotherapy and in Combination to Subjects with Unresectable Hepatocellular Carcinoma

Investigation of Safety of Investigational Medications in Liver Cancer Treatment

Recruiting
18 years and older
All
Phase N/A
  • Simplified description (AI rewritten)
  • Technical description (Original)

This study investigates the safety of two investigational medications in treating adults with liver cancer that cannot be removed by surgery. The medications are being tested alone and in combination to evaluate their effects on liver cancer, also known as hepatocellular carcinoma.

Participants in this study will undergo treatment with either one of the investigational medications or a combination of both. The study will monitor the safety and effects of these treatments on the participants.

  • Who can participate: Adults aged 18 years or older with liver cancer that cannot be removed by surgery are eligible. Participants may have a diagnosis with or without viral hepatitis B or C infection.
  • Study details: Participants will receive treatment with investigational medications. The study will monitor the safety of these medications. If applicable, a placebo will be used to compare against the investigational treatments.
Print
Study details
    liver cancer
    hepatocellular carcinoma

TX5911

19 February 2024

Contact a study center
Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team

Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Preferred way of contact label
Please provide your preferred way of contact1234
Other language

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.